IGF-1 LR3 and PEG-MGF Interaction

Monitor
Researched 90% confidence

IGF-1 LR3 and PEG-MGF have an interaction requiring monitoring for interaction with 90% confidence. Both target IGF-1 pathways; combining risks receptor overstimulation. Reduce doses significantly if combined. Both compounds affect the blood vessels and pituitary, so monitoring these systems is recommended.

Compound Profiles

IGF-1 LR3

Modified Growth Factor Analog | Muscle Growth

Functions as a full IGF-1 receptor agonist activating PI3K/Akt/mTOR and MAPK/ERK pathways. The modifications prevent protein sequestration, maintaining elevated free circulating levels for extended anabolic effects.

Half-life: 20-30 hours Typical dose: 20-100 mcg daily (start low at 20-30 mcg) growth hormone, healing
igf1mtor carcinogenic riskinsulin disrupting
View full profile

PEG-MGF

Pegylated Mechano Growth Factor | IGF-1 Splice Variant

Activates muscle satellite stem cells via receptor binding, stimulating MAPK/ERK signaling. Enhances protein synthesis and promotes muscle fiber repair.

Half-life: 48-72 hours (via PEGylation) Typical dose: 200-400mcg per injection growth hormone, healing
igf1 carcinogenic riskinsulin disruptingteratogenic
View full profile

Combined Organ Load

Blood Vessels
low
Pituitary
low

Shared Safety Flags

2x 2 compounds share the carcinogenic-risk safety flag (IGF-1 LR3, PEG-MGF). Monitor accordingly.
2x 2 compounds affect insulin sensitivity (IGF-1 LR3, PEG-MGF). Monitor fasting glucose and HbA1c.

Frequently Asked Questions

Can I take IGF-1 LR3 with PEG-MGF?

Yes, but with caution. Both target IGF-1 pathways; combining risks receptor overstimulation. Reduce doses significantly if combined. Regular monitoring is advised.

Is IGF-1 LR3 and PEG-MGF safe together?

Based on documented research, this combination is considered monitor. However, shared safety flags include: carcinogenic risk, insulin disrupting. Monitor accordingly.

What are the interactions between IGF-1 LR3 and PEG-MGF?

Both target IGF-1 pathways; combining risks receptor overstimulation. Reduce doses significantly if combined. This assessment has 90% confidence and is based on documented research data.

How should I time IGF-1 LR3 and PEG-MGF?

IGF-1 LR3 has a half-life of 20-30 hours and PEG-MGF has a half-life of 48-72 hours (via PEGylation). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: IGF-1 LR3 vs PEG-MGF

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.